Richard D Gelber Selected Research

Goserelin (Zoladex)

1/2019	Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230.
1/2015	Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.
3/2008	Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
1/2007	Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII.
12/2003	Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard D Gelber Research Topics

Disease

134	Breast Neoplasms (Breast Cancer) 02/2022 - 03/2003
51	Neoplasms (Cancer) 11/2022 - 04/2002
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2007 - 03/2002
4	Cardiotoxicity 02/2022 - 03/2002
4	Cardiovascular Diseases (Cardiovascular Disease) 02/2021 - 12/2005
4	Heart Failure 01/2020 - 12/2002
4	Amenorrhea 01/2019 - 03/2006
4	Hypercholesterolemia 04/2017 - 12/2005
3	Triple Negative Breast Neoplasms 12/2021 - 06/2010
3	Lobular Carcinoma 10/2021 - 06/2013
3	Arthralgia (Joint Pain) 01/2018 - 02/2007
3	Hot Flashes 11/2016 - 01/2007
3	Acquired Immunodeficiency Syndrome (AIDS) 06/2007 - 07/2002
2	Left Ventricular Dysfunction 02/2022 - 12/2002
2	Diarrhea 01/2020 - 07/2017
2	Premature Menopause 01/2019 - 07/2007
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 01/2018
2	Lung Neoplasms (Lung Cancer) 01/2019 - 04/2002
2	Pathologic Complete Response 01/2019 - 04/2016
2	Hypertension (High Blood Pressure) 01/2018 - 12/2007
2	Obesity 11/2012 - 01/2010
2	Bone Fractures (Bone Fracture) 04/2008 - 02/2007
2	Uterine Hemorrhage (Uterine Bleeding) 02/2007 - 12/2005
1	Myocardial Ischemia (Ischemic Heart Diseases) 02/2021
1	Overweight 10/2020
1	Autoimmune Diseases (Autoimmune Disease) 02/2019
1	Spontaneous Abortion (Miscarriage) 01/2019
1	Melanoma (Melanoma, Malignant) 01/2018
1	Vaginal Discharge 10/2016
1	Leukopenia 10/2016
1	Polyps 01/2016
1	Adenoma (Adenomas) 01/2016
1	Ductal Carcinoma 09/2015
1	Exanthema (Rash) 09/2014
1	Neutropenia 09/2014
1	Erythema 09/2014

Drug/Important Bio-Agent (IBA)

45	Tamoxifen FDA LinkGeneric 02/2021 - 09/2003
41	Hormones (Hormone)IBA 10/2021 - 10/2004
32	Trastuzumab (Herceptin)FDA Link 02/2022 - 10/2005
28	Letrozole (Femara)FDA LinkGeneric 02/2021 - 12/2005
25	Estrogen ReceptorsIBA 01/2020 - 03/2003
13	Aromatase InhibitorsIBA 02/2021 - 12/2005
13	human ERBB2 proteinIBA 01/2021 - 06/2009
12	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 03/2003
12	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 04/2003
10	ErbB Receptors (EGF Receptor)IBA 01/2021 - 07/2013
9	Methotrexate (Mexate)FDA LinkGeneric 10/2016 - 04/2003
8	Lapatinib (GW572016)FDA Link 01/2021 - 02/2012
8	exemestane (Aromasin)FDA Link 01/2020 - 07/2014
7	Fluorouracil (Carac)FDA LinkGeneric 06/2010 - 04/2003
7	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2010 - 03/2002
6	Estrogens (Estrogen)FDA Link 12/2015 - 09/2007
5	pertuzumabIBA 01/2022 - 07/2017
5	Biomarkers (Surrogate Marker)IBA 12/2021 - 03/2003
5	Goserelin (Zoladex)FDA Link 01/2019 - 12/2003
5	SteroidsIBA 11/2011 - 10/2004
4	Paclitaxel (Taxol)FDA LinkGeneric 02/2022 - 09/2014
4	Biological ProductsIBA 12/2021 - 12/2005
4	Monoclonal AntibodiesIBA 01/2017 - 10/2005
4	Nevirapine (Viramune)FDA Link 06/2007 - 07/2002
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 10/2019 - 12/2003
3	DNA (Deoxyribonucleic Acid)IBA 12/2015 - 06/2010
3	Progesterone FDA LinkGeneric 04/2013 - 09/2007
3	AnthracyclinesIBA 08/2010 - 01/2006
2	Immune Checkpoint InhibitorsIBA 11/2022 - 01/2018
2	Ado-Trastuzumab EmtansineIBA 02/2022 - 01/2021
2	Phenobarbital (Luminal)FDA Link 10/2021 - 10/2019
2	Estrogen Receptor alphaIBA 11/2016 - 12/2015
2	Epidermal Growth Factor (EGF)IBA 04/2016 - 02/2014
2	Pharmaceutical PreparationsIBA 09/2014 - 03/2002
2	Proteins (Proteins, Gene)FDA Link 11/2012 - 04/2003
2	Docetaxel (Taxotere)FDA Link 01/2010 - 01/2008
2	Epirubicin (Ellence)FDA LinkGeneric 01/2009 - 01/2006
1	Poly Adenosine Diphosphate RiboseIBA 01/2021
1	olaparibIBA 01/2021
1	antineoplaston A10 (A 10)IBA 01/2020
1	AntidiarrhealsIBA 01/2020
1	taxaneIBA 01/2020
1	acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamide FDA Link 10/2019
1	Triptorelin Pamoate (Trelstar)FDA Link 10/2019
1	Cyclin D1IBA 01/2018
1	CholesterolIBA 04/2017
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 11/2016
1	Transaminases (Aminotransferases)IBA 10/2016
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2016
1	Hematoxylin (Haematoxylon)IBA 01/2016
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2016
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2016

Therapy/Procedure

78	Therapeutics 10/2021 - 07/2002
50	Drug Therapy (Chemotherapy) 01/2022 - 04/2002
22	Adjuvant Chemotherapy 01/2021 - 04/2003
8	Radiotherapy 01/2018 - 07/2004
3	Immunotherapy 11/2022 - 01/2018
3	Neoadjuvant Therapy 02/2022 - 02/2008
3	Mastectomy (Mammectomy) 01/2018 - 06/2008
3	Segmental Mastectomy (Lumpectomy) 10/2016 - 06/2008
1	Induced Abortion (Induced Abortions) 01/2019
1	Aftercare (After-Treatment) 01/2019
1	Maintenance Chemotherapy 01/2016
1	Chemoprevention 01/2016